These findings show that low expression level of SMAD5 in gastrointestinal cancer results in higher OS in gastric cancer patients (HR = 2.31 (1.6–3.32) P = 3.7e-06, Figure 5(b)). This evidence concerns the gene SMAD5 and gastric cancer.